T1	p 61 103	patients with alcoholic liver disease -- a
T2	p 438 566	patients with alcoholic liver disease . Fifty patients with alcoholic liver disease ( 27 with cirrhosis , 23 without cirrhosis )
T3	p 896 917	15 healthy controls .
T4	p 1287 1302	the verum group
T5	p 1688 1727	patients with alcoholic liver disease .
T6	i 31 42	paromomycin
T7	i 119 137	placebo-controlled
T8	i 593 654	receive either paromomycin sulfate ( 3 x 1 g/day ) or placebo
T9	i 935 946	paromomycin
T10	i 950 957	placebo
T11	i 1125 1136	paromomycin
T12	i 1160 1167	placebo
T13	i 1316 1329	( paromomycin
T14	i 1352 1359	placebo
T15	i 1396 1407	paromomycin
T16	i 1547 1558	paromomycin
T17	o 46 57	endotoxemia
T18	o 423 434	endotoxemia
T19	o 730 776	Endotoxin concentration , liver function tests
T20	o 849 872	Endotoxin concentration
T21	o 1027 1064	Mean initial endotoxin concentrations
T22	o 1245 1273	mean endotoxin concentration
T23	o 1447 1470	endotoxin concentration
T24	o 1474 1494	liver function tests
T25	o 1572 1583	endotoxemia